Bleomycin-methotrexate-chemotherapy in combination with telecobalt-radiation for patients suffering from advanced oral carcinoma

20 patients suffering from advanced oral carcinoma (T3NXMO) were treated simultaneously with the cytostatics Bleomycin and Methotrexate and Telecobalt-radiation. 14 of them (70%) showed complete remission. Four relapses were treated by surgery. These patients are still alive and tumour-free. One patient with a tumour is also still alive. Five died of their tumours or other causes. As a preliminary result, overall survival of about 80% after the first year seems to be much higher than with other therapeutic procedures.